AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/16/2024 | Press release | Distributed by Public on 05/16/2024 06:41
Please select the service you want to use:
Smartlinks | Wendel SE | Company News | Top Company News | Shareholders | Shareholder Meeting | Buyback, Treasury Shares and Liquidity Agreements | Financial Services | Investment Services | Professional and Business Services | Legal Services | Securities Issuers | Investment Holding Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | Tradegate Exchange | Euronext Paris | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Aquis Exchange | SIGMA X MTF | Equiduct | Euronext Block MTF | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact